Trial Profile
Effects of QuetiapineXR in schizophrenic patients with cannabis abuse and/or cannabis induced psychosis -pilot study.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 11 Jun 2019
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- 28 Apr 2012 Official Title amended as reported by European Clinical Trials Database record.
- 28 Apr 2012 Planned number of patients 30 added as reported by Clinical Trials Databaserecord.
- 28 Apr 2012 New source identified and integrated (European Clinical Trials Database; EudraCT2008-000766-23).